News from emd serono, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 29, 2011, 13:53 ET

EMD Serono, Inc. Receives Gold LEED® Rating

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced that the company's state-of-the-art research center in Billerica,...

Mar 02, 2011, 02:25 ET
EMD Serono Logo 2.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Receives Complete Response Letter From FDA on Cladribine Tablets New Drug Application

ROCKLAND, Mass., March 2, 2011 – EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that it received a...

Feb 11, 2011, 17:36 ET
EMD Serono, Inc. today opened a state-of-the-art research center in Mass.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Holds Grand Opening Ceremony for New State-of-the-Art Research Center in Billerica, MA

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced the opening of a state-of-the-art research center in Billerica,...

Nov 26, 2010, 03:21 ET
EMD Serono Logo 1.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Announces Extension of FDA Priority Review Period for Cladribine Tablets for the Treatment of Relapsing Forms of Multiple Sclerosis

EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has extended its...

Nov 11, 2010, 07:35 ET

FDA Approves EGRIFTA™ (tesamorelin for injection): First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-infected Patients with Lipodystrophy

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced that the U.S. Food and Drug Administration (FDA) has approved...

Jul 28, 2010, 03:38 ET

EMD Serono, Inc.: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has accepted for...

Jan 21, 2010, 01:30 ET

Two-Year Results From CLARITY Study with Cladribine Tablets in Multiple Sclerosis Published in The New England Journal of Medicine

EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today the online publication of the results from the CLARITY(1) Phase III...

Dec 16, 2009, 08:00 ET

EMD Serono, Inc. and Nationally Ranked US Hospital Announce Collaboration in Basic and Clinical Research in Multiple Sclerosis

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced a strategic collaboration with Brigham and Women's Hospital in...

Nov 30, 2009, 09:06 ET

EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application

EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today that it received a refuse to file letter from the US Food and Drug...

Oct 19, 2009, 13:06 ET

Video: EMD Serono Holds Topping Off Ceremony to Mark Milestone in the Expansion of the Company's Billerica, MA Research Facility

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, marked the expansion of its research facility in Billerica, MA today,...

Oct 05, 2009, 10:46 ET

EMD Serono, Inc. Named as a Top Employer by Science Magazine

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that Science magazine has named it one of the world's...

Sep 30, 2009, 12:02 ET

EMD Serono Submits Application for Cladribine Tablets as a Potential Oral Short-Course Multiple Sclerosis Therapy in the United States

EMD Serono, Inc. an affiliate of Merck KGaA, Darmstadt, Germany, announced today the submission of a New Drug Application (NDA) to the...

Aug 10, 2009, 09:00 ET

EMD Serono, Inc. and The University of Texas M. D. Anderson Cancer Center Announce Collaboration for Preclinical Research, Clinical Trials

EMD Serono, Inc. and The University of Texas M. D. Anderson Cancer Center today announced a strategic alliance designed to provide M. D. Anderson...

Jun 16, 2009, 08:00 ET

Men Are Not 'In The Know' About Fertility

- New, Free Resource In The Know: What No One Tells You About Male Fertility Now Available for the 7.3 Million Americans Who Experience...

May 27, 2009, 07:42 ET

Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking?

- New national survey reveals insights on treatment of disease, psychosocial burden, and delays in starting treatment The National Multiple...

Mar 30, 2009, 08:00 ET

EMD Serono, Inc. Announces Expansion with Research Site in Cambridge, Massachusetts

- Supports US Drug Discovery Activities in Neurodegenerative Diseases- EMD Serono, Inc. announced today that it will open a site in Cambridge,...

Mar 18, 2009, 07:00 ET

EMD Serono and FAST FORWARD, LLC Announce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis

-- EMD Serono and Fast Forward agree to work together to speed research development on a select group of high potential MS research projects with...

Nov 07, 2008, 08:00 ET

EMD Serono Launches Landmark Patient Registry for Egg Freezing

ROCKLAND, Mass., Nov. 7 /PRNewswire/-- EMD Serono, Inc., an affiliate of Merck KGaA of Darmstadt, Germany, announced the launch of the Human...

Jul 10, 2008, 01:00 ET

EMD Serono to Adopt Revised and Strengthened PhRMA Code

ROCKLAND, Mass., July 10 /PRNewswire/ -- EMD Serono, Inc. announced today that the company has adopted and will fully implement, the revised and...

Apr 17, 2008, 01:00 ET

Women Want to Know More About Infertility According to Recent Survey

ROCKLAND, Mass., April 17 /PRNewswire/ -- Fertility LifeLines(TM) and Conceive Magazine today released new survey data illustrating the need for...